Podocyte globotriaosylceramide (GL-3) content in female...

Molecular Genetics and Metabolism 2020 / 02 Vol. 129; Iss. 2

Podocyte globotriaosylceramide (GL-3) content in female adult patients with Fabry disease and amenable mutations reduces following 6 months of treatment with migalastat

Najafian, Behzad, Sargolzaeiaval, Forough, Sokolovskiy, Alexey, Mauer, Michael
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
129
Journal:
Molecular Genetics and Metabolism
DOI:
10.1016/j.ymgme.2019.11.295
Date:
February, 2020
File:
PDF, 341 KB
2020
Conversion to is in progress
Conversion to is failed